Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Times Interest Earned (2019 - 2025)

Revolution Medicines (RVMD) has 5 years of Times Interest Earned data on record, last reported at -$27.59 in Q3 2025.

  • For Q3 2025, Times Interest Earned changed N/A year-over-year to -$27.59; the TTM value through Dec 2025 reached -$20.79, up 91.53%, while the annual FY2025 figure was -$9.8, 96.41% up from the prior year.
  • Times Interest Earned reached -$27.59 in Q3 2025 per RVMD's latest filing, up from -$50.15 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$27.59 in Q3 2025 and bottomed at -$3116.4 in Q1 2021.
  • Average Times Interest Earned over 3 years is -$1064.7, with a median of -$50.15 recorded in 2024.
  • The widest YoY moves for Times Interest Earned: up 210.43% in 2021, down 210.43% in 2021.
  • A 3-year view of Times Interest Earned shows it stood at -$3116.4 in 2021, then surged by 98.39% to -$50.15 in 2024, then soared by 44.99% to -$27.59 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were -$27.59 in Q3 2025, -$50.15 in Q1 2024, and -$3116.4 in Q1 2021.